Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Implantation-associated protein pseudogene (ENSG00000232862, also known as LOC100128093 or DKFZp564K142 pseudogene) is classified as a pseudogene located on chromosome 1[1][2]. Pseudogenes are nonfunctional segments of DNA with high sequence similarity to known functional genes but do not encode active proteins due to disabling mutations or processing errors[7]. They are generally not considered therapeutic targets because they lack protein-coding potential and do not directly mediate biological or pharmacological functions[2][7]. However, pseudogenes can sometimes act in gene regulation or serve as disease biomarkers by influencing gene expression at the RNA level, but no specific function or disease association is reported for this particular pseudogene[2][4]. This entry should not be considered a therapeutic target, and it is classified as “incorrect” in the context of drug discovery or target nomination because it is a pseudogene, not an active protein or receptor[2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Implantation-associated protein pseudogene.